Valuation: Becton, Dickinson and Company

Market Cap 41.87B 36.62B 33.78B 31.2B 59.19B 3,993B 60.19B 404B 158B 1,967B 157B 154B 6,762B P/E 2026 *
37.9x
P/E 2027 * 29.2x
Enterprise Value 57.82B 50.58B 46.65B 43.09B 81.75B 5,515B 83.13B 557B 219B 2,717B 217B 212B 9,339B EV / Sales 2026 *
3.01x
EV / Sales 2027 * 2.84x
Free-Float
74.04%
Yield 2026 *
2.53%
Yield 2027 * 2.58%
1 day+0.88%
1 week-0.75%
Current month+2.02%
1 month+6.09%
3 months-0.68%
6 months-23.39%
Current year-20.45%
1 week 148.23
Extreme 148.23
159.49
1 month 140.11
Extreme 140.11
159.49
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer - 29/11/2021
Director TitleAgeSince
Director/Board Member 65 26/03/2025
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Date Insider Type Main position Quantity % Market Cap.
07-02Tax

Executive/Senior Manager

-1,935 0.0007%
06-26Sell

Executive/Senior Manager

-75 0.0000%
06-24Sell

Executive/Senior Manager

-1,100 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%-0.75%-12.82%-40.61% 41.87B
-2.19%-3.24%-29.92%-14.12% 164B
+0.20%+1.85%-5.72%-3.92% 107B
+0.61%+3.18%+3.70%+61.04% 59.04B
+2.02%-0.37%+40.23%+55.65% 51.72B
+1.27%-2.33% - - 34.7B
-0.05%+3.87%-11.89%-43.89% 28.93B
+1.41%+0.55%+60.19%-6.27% 24.99B
+0.31%+2.12%-3.54%-4.78% 21.05B
+2.35%+4.52%-4.41%-17.91% 20.39B
Average +0.64%-0.83%+3.98%-1.65% 55.37B
Weighted average by Cap. -0.11%-0.85%-5.30%+0.31%

Financials

2026 *2027 *
Net sales 19.21B 16.8B 15.5B 14.31B 27.16B 1,832B 27.61B 185B 72.71B 902B 72.11B 70.54B 3,102B 19.71B 17.24B 15.9B 14.69B 27.87B 1,880B 28.34B 190B 74.62B 926B 74.01B 72.4B 3,184B
Net income 1.12B 984M 907M 838M 1.59B 107B 1.62B 10.84B 4.26B 52.84B 4.22B 4.13B 182B 1.45B 1.27B 1.17B 1.08B 2.05B 138B 2.08B 13.97B 5.49B 68.09B 5.44B 5.32B 234B
Net Debt 15.95B 13.96B 12.87B 11.89B 22.56B 1,522B 22.94B 154B 60.4B 750B 59.91B 58.6B 2,577B 14.07B 12.31B 11.35B 10.49B 19.9B 1,342B 20.23B 136B 53.27B 661B 52.84B 51.69B 2,273B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
13/07/26 US$154.31 +1.56% 119,012
10/07/26 US$151.94 +0.72% 1,048,174
09/07/26 US$150.85 +0.19% 1,788,623
08/07/26 US$150.56 -3.67% 2,287,663
07/07/26 US$156.30 +0.49% 1,757,628
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
151.94USD
Average target price
176.92USD
Spread / Average Target
+16.44%

Quarterly revenue - Rate of surprise